TGEN(TGEN)
TGEN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $28M | $62M |
| Low | $27M | $60M |
| High | $29M | $64M |
| EBITDA Avg | $-3M | $-6M |
| Low | $-3M | $-6M |
| High | $-3M | $-6M |
| EBIT Avg | $-3M | $-7M |
| Low | $-3M | $-8M |
| High | $-3M | $-7M |
| Net Income Avg | $-6M | $5M |
| Low | $-6M | $4M |
| High | $-6M | $6M |
| EPS Avg | $-0.22 | $0.18 |
| Low | $-0.23 | $0.15 |
| High | $-0.22 | $0.20 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $7M | $9M | $12M | $14M | $17M | $20M |
| Low | $6M | $8M | $11M | $13M | $15M | $19M |
| High | $7M | $10M | $13M | $15M | $18M | $22M |
| EBITDA Avg | $-650,574 | $-876,875 | $-1M | $-1M | $-2M | $-2M |
| Low | $-699,367 | $-951,794 | $-1M | $-1M | $-2M | $-2M |
| High | $-600,824 | $-818,243 | $-1M | $-1M | $-2M | $-2M |
| EBIT Avg | $-804,917 | $-1M | $-1M | $-2M | $-2M | $-2M |
| Low | $-865,286 | $-1M | $-2M | $-2M | $-2M | $-3M |
| High | $-743,364 | $-1M | $-1M | $-2M | $-2M | $-2M |
| Net Income Avg | $-2M | $-796,254 | $-99,520 | $696,704 | $2M | $3M |
| Low | $-2M | $-884,694 | $-110,574 | $636,143 | $2M | $3M |
| High | $-1M | $-727,040 | $-90,869 | $774,086 | $2M | $3M |
| EPS Avg | $-0.06 | $-0.03 | $-0.00 | $0.02 | $0.06 | $0.10 |
| Low | $-0.07 | $-0.03 | $-0.00 | $0.02 | $0.05 | $0.09 |
| High | $-0.05 | $-0.02 | $-0.00 | $0.03 | $0.06 | $0.11 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |